The quiet MedTech pivot to Latin America

The global MedTech industry is undergoing a subtle but significant strategic shift: according to the report “The LATAM Pivot: MedTech’s Quiet Response to U.S. Tariff Volatility”, many companies are rethinking their market-entry and supply-chain strategies and moving their attention toward Latin America (LATAM) in 2025. 

The report details that in April 2025, the U.S. administration imposed sweeping duties on over 180 countries, including direct tariffs on medical-device imports: 20% for EU goods, 24% for Japanese, and up to 54% for Chinese devices. These measures have increased supply-chain risk and raised the cost of traditional export pathways. 

In response, Latin America is emerging as a strategic alternative: driven by growing healthcare demand, ageing demographics, investment in hospital infrastructure and relatively fewer trade-barrier complications compared with the U.S. The report suggests that a number of MedTech firms are shifting attention to LATAM to diversify risk and access emerging-market growth.

Sources:

• “The LATAM Pivot: MedTech’s Quiet Response to U.S. Tariff Volatility.” Nunex. Link

• “Tariffs on Medical Devices: Global Trade Disruptions in MedTech.” PTC Blog, Aug 2025. Link